Why Summits’ cover photo
Why Summits

Why Summits

Events Services

Bratislava, Slovakia 8,772 followers

Meet Leaders. Discuss Challenges. Transform your Ecosystem.

About us

Our events, conferences and trainings are designed to inspire and connect industry professionals from all corners of the world. Together with our growing community of speakers, attendees and stakeholders, we create a platform to build relationships and discuss pressing challenges, opportunities, strategies, processes, products, and cutting-edge innovation. We are currently mainly focusing on Three World Tours of strategic conferences at various locations globally: Pharma, Biotech, Medical Devices Vigilance and Safety Pharma, Biotech Manufacturing and Capital Expenditure Pharma, Biotech, Medical Devices Project, Program and Portfolio Management

Industry
Events Services
Company size
11-50 employees
Headquarters
Bratislava, Slovakia
Type
Privately Held
Specialties
Healthcare, Digitalization, Pharmaceuticals, MedTech, Biopharma, Innovation, Agile Project Management, Key Account Management, and Digitalization of Healthcare

Locations

Employees at Why Summits

Updates

  • Lev K. - thank you for sharing your experience with us at the Pharma Partnering Conference in Basel. These practical Do’s and Don’ts truly resonated with many in the room. 💡🤝 #WhySummits #PharmaPartnering #BusinessDevelopment #BSPT0425

    View profile for Lev K.

    Vice President, Head of Business Development

    💡 Navigating the BD Life Cycle: Value Drivers & Lessons from Both Sides of the Table. It was a pleasure to speak at the Pharma Partnering Summit in Basel this week. I shared insights on the Business Development life cycle—from strategic fit and partner scouting to deal structuring and alliance execution—drawing on my experience in both Pharma and Biotech. Thank you to the organizers for the kind invitation, to the engaged audience for the thoughtful Q&A, and to the fantastic summit chairman, Luis, for setting the tone. 🔍 Some of the most resonant Do’s & Don’ts discussed: For Biotech: ✔️ Come prepared—know your data and your competition ✔️ Understand your partner’s unmet needs and gaps ✔️ Surround yourself with experienced advisors ❌ Don’t cold-email without doing your homework ❌ Don’t overpromise or inflate timelines For Pharma: ✔️ Provide specific, actionable feedback (e.g. on experiment design, models, or indications) ✔️ Engage early and constructively—even if you’re not ready to deal ✔️ Ensure eye-to-eye conversations with respect and clarity ❌ Don’t ghost—uncertainty often pushes Biotechs to cast a wider net, which adds unnecessary noise and effort on both sides 🤝 At the end of the day, successful partnerships come down to mutual respect, transparency, and long-term value creation. 📩 If you'd like a copy of the slide deck, feel free to comment below and I’ll gladly share it! Let’s keep the conversation going—what do you see as the most important BD Do’s and Don’ts in your experience? #PharmaPartnering #BusinessDevelopment #Biotech #Pharma #DealMaking #AllianceManagement #BDLifecycle #ValueCreation

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
  • 🔍 Compassionate Use in Drug Asset Transition: The Forgotten Patient At the Pharma Partnering Conference in Basel, Ana Paula Tediosi, Head of Expanded Access Program Strategy at WEP Clinical, shared an insightful case study on compassionate use programs (CUP). This often-overlooked aspect of drug asset transition is vital, especially for patients outside of clinical trials, who sometimes get lost during the transition process. With a focus on oncology, neurology, and rare diseases, Ana provided valuable takeaways on how to ensure no patient is forgotten in the asset transition process. 🔥 Don’t miss more sessions like this at our upcoming events. 👉 https://lnkd.in/d6A8TYC9 #BSPT0425 #WhySummits #PharmaPartnering #DrugSafety #PatientSafety

    • No alternative text description for this image
  • 🔑 Mastering M&A: Tillotts Pharma’s Successful Journey to Becoming a Leading European Specialty Pharma At the Pharma Partnering Conference in Basel, Ragip M Ziyal, PhD, MBA, Head of Corporate Development at Tillotts Pharma AG, shared a powerful case study on how the company has successfully navigated mergers and acquisitions. He walked us through the lessons learned from recent M&A deals, highlighting Tillotts’ strategy and their approach to integrating assets, executing deals quickly, and navigating a multi-cultural environment. This session was a valuable example of how strategic partnerships drive success in the specialty pharma world! 🌍 🔥 Stay tuned for more sessions like this at our upcoming events. 👉 Check out our upcoming conferences: https://lnkd.in/duAE-a-5 #BSPT0425 #WhySummits #StrategicPartnerships #PharmaLeadership

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
  • 🚀 What an incredible time we had at the Pharma Partnering Conference in Basel! 💥 The event brought together some of the brightest minds in pharma, where we explored new trends, innovation, and how partnerships are shaping the future of the industry. From cutting-edge strategies in business development to tackling the challenges of global collaborations, it was an inspiring two days full of insights and meaningful discussions. 🌍💡 A huge thank you to all the incredible speakers who made this event truly memorable: Ana Paula Tediosi – Head of Expanded Access Program Strategy, WEP Clinical Benjamin Fischer – VP Global Alliance & Integration Management, STADA Group Charlie Bailey – BD&L Transactions Head, Global Health, Corporate & Business Development, Novartis AG Delphine Demeestere, PhD, MBA – Director of External Innovation, Lonza Fadi Eskandar, MMD / PhD / MBA – SVP, Head of External Ecosystem Collaboration and Partnership, Innovative Assets, Dr. Reddy’s Laboratories Gabriela M. Visser, PhD – Founder & CEO, Q-Pro Laboratories B.V. Hiroyuki Usuda – Scouting & Transaction Lead, Business Development, Astellas Pharma Huseyin Ocak – Global Alliance Management Lead, Consumer Healthcare, Opella Isabella Visconti CA-AM, EMBA – Founder, Visconti Alliance Management Jari Kaunisto – Business Development Director, Orion Corporation Jean-Eric Charoin – Global S&E Lead CVM, Immunology and Infectious Diseases, Pharma Partnering, Roche Lev K. – VP, Head of Business Development, Nykode Therapeutics Louise Jopling – Chief Scientific & Innovation Officer, Babraham Research Campus Luis Correia – Founder & CEO, Basel Biotech Consulting Michael R Huebner – Director, Country Lead Switzerland, Early Innovation Partnering, Johnson & Johnson Ragip M Ziyal, PhD, MBA – Head of Corporate Development, Tillotts Pharma Rainer Strohmenger – Managing Partner, Wellington Partners Ricardo Gaminha Pacheco – Strategic Partnering, Business Development & Licensing Director, Insilico Medicine Seda Larsen – Senior Director Global Alliance & Asset Management, Roche Sönke Johannsen – Global Director, Advanced Therapies & Integrated Solutions Rare Disease, Novo Nordisk Ulrich Betz – VP of Innovation, Chairman of the Board Future Insight, Merck Xiaona J. – SVP Global Product Development & Partnering at Multitude Therapeutics Ying Wang – Senior Director of Business Development, Roche 🚀 A special thank you to our sponsors for making this event possible: Tillotts Pharma AG WEP Clinical Delta4ai 💥 What’s NEXT? Ready to level up your knowledge, strategies, and connections? 📢 Stay tuned for exciting updates on our upcoming Pharma Partnering Conferences - more details coming soon! 👉 Check out here: https://lnkd.in/duAE-a-5 #PharmaPartnering #Healthcare #WhySummits #BSPT0425  

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
      +8
  • 🤝🔥 The Ultimate Guide to Pharma Project Success: Leadership, Strategy, and Effective Team Collaboration! Get ready for transformative insights from industry leaders at our upcoming conference in Philadelphia! Here’s a preview of the exciting keynote sessions that will help you accelerate success in your projects: 1️⃣ Building a Solid Business Case for Digital Transformation Join Marisol Plaza, Sr. Director of IT, Program Management at Bausch Health Companies Inc., as she explains how creating a strong business case for digital projects can drive long-term success, improve decision-making, and support continuous transformation. 2️⃣ How Leadership Drives Cross-Functional Collaboration in Pharma Leadership is more than decision-making — Vishal Saxena (PhD, MBA), Sr. Director, Business Development, Integration & Alliance, Strategic Partnerships & Program Management, GPS Strategy of Bristol Myers Squibb, will show how leadership fosters cross-functional collaboration, speeds up communication, and brings therapies to market faster and smarter. 3️⃣ Optimizing Relationships for Successful Project Delivery In this keynote, Saloni Desai, Associate Director, Program Management at Noven Pharmaceuticals, discusses how blending emotional intelligence with core project management skills enhances collaboration, productivity, and project success in an ever-evolving landscape. Don’t miss the chance to hear from these leaders and gain practical insights on driving your projects forward! 🚀 🔗 Register now and elevate your project management game! 📅👉 https://lnkd.in/d8c4dXbj #PHPM0425 #WhySummits #PharmaInnovation #LeadershipInPharma #ProjectSuccess #DigitalTransformation #CollaborationInAction #Philadelphia2025

  • ⚡📊 Speed, Quality, and Efficiency: Mastering Empowered Decision-Making in Pharma With industry leaders like Darshan S., Executive Director, Global Program Management, Incyte, Kris Sprague, Director, Program Management, Ultragenyx, Vishal Saxena (PhD, MBA), PhD, MBA, Sr. Director, Business Development, Integration & Alliance, Strategic Partnerships & Program Management, GPS Strategy, BRYSTOL MYERS SQUIBB SL, Marion McGlynn, Head, Program Management, Amylyx Pharmaceuticals, Tanya Kranenburg, PhD, PMP, Director, Research Portfolio Management, Reporting & Analytics, Regeneron this session will explore how organizations accelerate strategy execution, establish transparency, and ensure confident, high-quality decision-making in a fast-paced environment. Learn how speed, quality, and efficiency come together to create a winning formula for achieving strategic objectives. Don’t miss this game-changing conversation — register today and unlock the secrets to better decision-making in pharma! 📅💥👉 https://lnkd.in/d8c4dXbj #PHPM0425 #WhySummits #PharmaDecisions #SpeedQualityEfficiency #StrategicSuccess #Philadelphia2025

    • No alternative text description for this image
  • Level Up with 3 Must-Attend Workshops: Scenario Planning, Data, and AI! 🔥 Get ready to deepen your knowledge and sharpen your skills with our engaging workshops designed for pharma and biotech professionals on the second day of the 24th American Pharma and Biotech Project, Program and Portfolio Management Conference in Philadelphia. Here’s a sneak peek of what we have in store: 1️⃣ Strategic Scenario Planning for Project Success Join Marion McGlynn, Head of Program Management at Amylyx Pharmaceuticals, to explore the power of strategic scenario planning in improving project resilience and success. Learn how to create flexible plans, anticipate challenges, and adapt strategies to uncertain market conditions. 2️⃣ Data Visualization Techniques for Enhanced Decision-Making In this workshop, Mark Kleinman, Senior Project Director at CSL, will show you how to use data visualization tools to present data clearly and make more informed decisions. You’ll also get hands-on experience in creating dashboards and visual reports that support critical decision-making processes. 3️⃣ Risk Management Fundamentals for Pharma and Biotech: Navigating the Challenges of Artificial Intelligence Join Beth Grimm, Founder & Principal of @Beth Grimm Leadership Consulting, for an interactive workshop to learn how to manage AI-related risks in pharma and biotech. Gain insights into developing an effective risk strategy while understanding AI’s impact. These workshops are tailored to equip you with practical skills and insights to excel in the evolving pharma and biotech landscape. Don’t miss your chance to learn from industry leaders — register today to secure your spot! 📅✨👉 https://lnkd.in/d8c4dXbj #PHPM0425 #WhySummits #PharmaWorkshops #ProjectManagement #RiskManagement #AIinPharma #Philadelphia2025

  • 🎤💥 Get ready for Day 2 of the 24th American Pharma and Biotech Project, Program and Portfolio Management Conference with the incredible Sachin Raje leading the way! Join Sachin Raje, Director of Strategy Realization Office, MRL GMSA at Merck, as he takes the reins and guides us through another day of cutting-edge insights and meaningful discussions. With his expertise in strategy and innovation, Sachin is sure to make Day 2 a memorable one! Don’t miss out—register now! 📅🔥👉 https://lnkd.in/d8c4dXbj #PHPM0425 #WhySummits #Leadership #PharmaInnovation #Basel2025

    • No alternative text description for this image
  • 🤖💡 AI-Powered Project Management: How AI is Transforming Drug Development and Portfolio Management What’s the real impact of AI in drug development and project management? Join Darshan S., Executive Director, Global Program Management, Incyte, Kelvin Roddy, Ph.D, MBA, Senior Director Program and Portfolio Management, Alexion Pharmaceuticals, Inc., Christopher Vandepas, Senior Director Program Management, SAGA Diagnostics, James Bonini, Executive Director Research IT, Regeneron, Beth Grimm, Founder & Principal, @Beth Grimm Leadership Consulting, Tim Mikhelashvili, Chief Executive Officer and Co-Founder, Amedea Pharma as they uncover how AI-driven tools are optimizing pipeline prioritization, enhancing workflow management, and enabling faster, smarter decision-making. The panel will also dive into real-world examples, shedding light on AI’s evolving role in pharma project management. Want to see how AI can revolutionize your pharma projects? Join us in Philadelphia and register today! 🔑👉 https://lnkd.in/d8c4dXbj #PHPM0425 #WhySummits #AIforPPM #PharmaInnovation #DrugDevelopment #Philadelphia2025

    • No alternative text description for this image
  • 💡💼 Building a Service-Driven PMO: The Key to Delivering Value and Driving Success What’s the secret to making your PMO indispensable? Kris Sprague, Director of Program Management at Ultragenyx, will tell you how embracing the service-provider mindset can help PMOs drive success and achieve strategic goals in today’s complex business environment. Don’t miss this chance to transform your PMO into a powerhouse — register now! 📅💥👉 https://lnkd.in/d8c4dXbj #PHPM0425 #WhySummits #PMOExcellence #ProgramManagement #PharmaInnovation #Philadelphia2025

    • No alternative text description for this image

Affiliated pages

Similar pages